Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study
Journal article
Imwong M. et al, (2020), The Lancet Infectious Diseases
Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.
Journal article
Saito M. et al, (2020), BMC medicine, 18
Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.
Journal article
Saito M. et al, (2020), The Lancet. Infectious diseases
Plasmodium falciparum ATP4 inhibitors to treat malaria: worthy successors to artemisinin?
Journal article
Ashley EA. and Phyo AP., (2020), The Lancet. Infectious diseases
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
Journal article
van der Pluijm RW. et al, (2020), The Lancet, 395, 1345 - 1360
Evaluation of the forum theatre approach for public engagement around antibiotic use in Myanmar.
Journal article
Swe MMM. et al, (2020), PloS one, 15
Genomic structure and diversity of Plasmodium falciparum in Southeast Asia reveal recent parasite migration patterns
Journal article
Shetty AC. et al, (2019), Nature Communications, 10
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
Journal article
Commons RJ. et al, (2019), BMC Medicine, 17
An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples
Journal article
Pearson RD. et al, (2019)
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
Journal article
Commons RJ. et al, (2019), PLOS Medicine, 16, e1002928 - e1002928
New malaria maps.
Journal article
Nosten FH. and Phyo AP., (2019), Lancet (London, England), 394, 278 - 279
Plasmodium vivax Relapse Rates Following Plasmodium falciparum Malaria Reflect Previous Transmission Intensity.
Journal article
Ashley EA. et al, (2019), The Journal of infectious diseases, 220, 100 - 104
Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
Journal article
Chu CS. et al, (2019), Clinical Infectious Diseases, 68, 1311 - 1319
Poor response to artesunate treatment in two patients with severe malaria on the Thai–Myanmar border
Journal article
Phyo AP. et al, (2018), Malaria Journal, 17
The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background
Journal article
Zhu L. et al, (2018), Nature Communications, 9
Comparison of the Cumulative Efficacy and Safety of Chloroquine, Artesunate, and Chloroquine-Primaquine in Plasmodium vivax Malaria
Journal article
Chu CS. et al, (2018), Clinical Infectious Diseases, 67, 1543 - 1549
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis
Journal article
Commons RJ. et al, (2018), The Lancet Infectious Diseases, 18, 1025 - 1034
Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing
Journal article
Ali AM. et al, (2018), Antimicrobial Agents and Chemotherapy, 62
Drugs in Development for Malaria
Journal article
Ashley EA. and Phyo AP., (2018), Drugs, 78, 861 - 879